An Ambiguous NUDT15 Signal in a Child with B-cell Acute Lymphoblastic Leukemia
- PMID: 40746189
- PMCID: PMC12314291
- DOI: 10.1093/clinchem/hvaf028
An Ambiguous NUDT15 Signal in a Child with B-cell Acute Lymphoblastic Leukemia
Conflict of interest statement
Similar articles
-
Commentary on An Ambiguous NUDT15 Signal in a Child with B-Cell Acute Lymphoblastic Leukemia.Clin Chem. 2025 Aug 1;71(8):840-841. doi: 10.1093/clinchem/hvaf069. Clin Chem. 2025. PMID: 40746188 No abstract available.
-
Commentary on An Ambiguous NUDT15 Signal in a Child with B-Cell Acute Lymphoblastic Leukemia.Clin Chem. 2025 Aug 1;71(8):839-840. doi: 10.1093/clinchem/hvaf042. Clin Chem. 2025. PMID: 40746187 No abstract available.
-
T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop.Am J Clin Pathol. 2025 Jul 11;164(1):26-35. doi: 10.1093/ajcp/aqaf015. Am J Clin Pathol. 2025. PMID: 40646675
-
Osteoarticular manifestation of acute lymphoblastic leukemia in adults: a literature review.Clin Rheumatol. 2023 Feb;42(2):607-620. doi: 10.1007/s10067-022-06459-7. Epub 2022 Dec 1. Clin Rheumatol. 2023. PMID: 36454343
-
Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: An Economic Analysis.Ont Health Technol Assess Ser. 2016 Mar 8;16(8):1-83. eCollection 2016. Ont Health Technol Assess Ser. 2016. PMID: 27099644 Free PMC article.
References
-
- Pratt VM, Cavallari LH, Fulmer ML, Gaedigk A, Hachad H, Ji Y, et al. TPMT and NUDT15 genotyping recommendations: a joint consensus recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase. J Mol Diagn 2022;24:1051–63. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources